These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21328222)

  • 1. Jaw-opening dystonia: Quality of life after botulinum toxin injections.
    Charous SJ; Comella CL; Fan W
    Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
    Gudex CM; Hawthorne MR; Butler AG; Duffey P
    Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-Aided Design/Computer-Assisted Manufacture-Derived Needle Guide for Injection of Botulinum Toxin into the Lateral Pterygoid Muscle in Patients with Oromandibular Dystonia.
    Yoshida K
    J Oral Facial Pain Headache; 2018 Spring; 32(2):e13-e21. PubMed ID: 29694466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of botulinum toxin in head and neck disorders.
    Hawthorne MR
    Hosp Med; 2003 Aug; 64(8):460-3. PubMed ID: 12958756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Rated Communication-Related Quality of Life of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin Injections.
    Page AD; Siegel L; Jog M
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):674-681. PubMed ID: 28654948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.